Short not on plasma proteins(its values) and their functions and write a short note on A/G ratio for 5 marks

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have all the content needed. Here is a well-structured 5-mark answer:

Plasma Proteins - Values and Functions

Normal Values

Protein Fraction	Normal Value
Total plasma protein	6.0 - 8.0 g/dL
Albumin	3.5 - 5.0 g/dL (~60% of total)
Globulins (total)	2.0 - 3.5 g/dL
- α1-globulins	0.2 - 0.4 g/dL
- α2-globulins	0.5 - 0.9 g/dL
- β-globulins	0.6 - 1.1 g/dL
- γ-globulins	0.7 - 1.7 g/dL
Fibrinogen	0.2 - 0.4 g/dL

Functions of Plasma Proteins

1. Oncotic (Osmotic) Pressure Maintenance

Plasma proteins, mainly albumin, exert an osmotic (oncotic) pressure of ~25 mm Hg across the capillary wall. This draws fluid back into the capillaries at the venous end and prevents edema. Albumin alone accounts for 70-80% of this osmotic pressure despite contributing ~60% of total protein by weight.

2. Transport / Carrier Function

Plasma proteins carry many insoluble or poorly soluble substances:

Albumin: carries free fatty acids, bilirubin, calcium, zinc, copper, steroid hormones, and numerous drugs (e.g. penicillin, aspirin, warfarin)
Transferrin: transports iron
Ceruloplasmin: transports copper
Haptoglobin: binds free hemoglobin
Thyroxine-binding globulin (TBG): transports thyroid hormones
Transcortin (CBG): transports cortisol and other corticosteroids
Transthyretin: transports T4 and retinol-binding protein

3. Immune Defense

Immunoglobulins (IgG, IgA, IgM, IgD, IgE), found in the γ-globulin fraction, are antibodies synthesized by lymphocytes. Complement proteins also serve in innate immunity.

4. Blood Coagulation

Fibrinogen (Factor I) and all coagulation factors except Factor VIII are plasma proteins synthesized by the liver. They are essential for hemostasis and fibrinolysis (e.g., plasminogen).

5. Buffering Capacity

Plasma proteins contribute ~15% of the total buffering capacity of the blood due to the ionizable -COOH and -NH2 groups. At pH 7.4, they are predominantly in anionic form.

6. Acute Phase Response

Proteins like C-reactive protein (CRP), α1-antitrypsin, haptoglobin, and α1-acid glycoprotein are acute phase proteins that rise rapidly during inflammation and tissue damage.

7. Enzyme Activity

Some plasma proteins function as enzymes within the blood (e.g., coagulation factors, cholinesterase) or "leak" from damaged tissues into blood (e.g., aminotransferases).

A/G Ratio (Albumin to Globulin Ratio)

Definition

The A/G ratio is the ratio of serum albumin to total serum globulin.

Globulin = Total protein - Albumin A/G ratio = Albumin / Globulin

Normal Value

1.2 : 1 to 1.8 : 1 (generally stated as >1, i.e., albumin normally exceeds globulin)

Significance

The A/G ratio is clinically useful because disease states typically depress albumin and raise globulins simultaneously, causing an exaggerated shift in the ratio (numerator falls while denominator rises).

Condition	Effect on A/G Ratio
Liver disease (cirrhosis, hepatitis)	Decreased (albumin synthesis falls)
Nephrotic syndrome	Decreased (urinary albumin loss)
Malnutrition / Malabsorption	Decreased (albumin synthesis falls)
Multiple myeloma	Reversed (marked globulin rise)
Autoimmune hepatitis	Reversed (polyclonal IgG rises)
Primary biliary cirrhosis	Reversed (polyclonal IgM rises)
Kala-azar (visceral leishmaniasis)	Reversed (greatly increased IgG)
Normal / Well-nourished state	>1

Why is Reversal Significant?

A reversed A/G ratio (<1) indicates either decreased albumin synthesis, increased albumin loss, or increased immunoglobulin production. Albumin synthesis decreases early in protein malnutrition (kwashiorkor) and liver disease, making the A/G ratio a sensitive marker of these conditions.

Note: While the A/G ratio was widely used historically, serum protein electrophoresis (SPEP) is now more informative as it separates the five major fractions (albumin, α1, α2, β, γ) individually and can identify a monoclonal spike in conditions like myeloma.

Sources: Ganong's Review of Medical Physiology (26e); Harper's Illustrated Biochemistry (32e); Basic Medical Biochemistry - A Clinical Approach (6e); Henry's Clinical Diagnosis and Management by Laboratory Methods

For mbbs first year

Here is the same content rewritten for MBBS 1st year (Biochemistry level) - concise, exam-focused, and easy to write in 5 marks:

Plasma Proteins - Values, Functions & A/G Ratio

(5 Marks)

Plasma Proteins - Normal Values

Fraction	Normal Value
Total Plasma Protein	6.0 - 8.0 g/dL
Albumin	3.5 - 5.0 g/dL
Globulins	2.0 - 3.5 g/dL
Fibrinogen	0.2 - 0.4 g/dL

Albumin makes up ~60% of total plasma protein
Site of synthesis: Liver (except immunoglobulins, which are made by plasma cells/B lymphocytes)

Functions of Plasma Proteins

1. Maintenance of Osmotic (Oncotic) Pressure

Plasma proteins, mainly albumin, maintain a colloid osmotic pressure of ~25 mm Hg. This prevents leakage of fluid into tissues. Loss of albumin → edema (e.g., nephrotic syndrome, kwashiorkor).

2. Transport Function

Proteins carry insoluble substances in blood:

Albumin - free fatty acids, bilirubin, Ca²⁺, drugs (aspirin, penicillin, warfarin)
Transferrin - iron
Ceruloplasmin - copper
Haptoglobin - free hemoglobin
TBG (Thyroxine Binding Globulin) - thyroid hormones
Transcortin - cortisol

3. Role in Blood Coagulation

Fibrinogen and all clotting factors (except Factor VIII) are plasma proteins synthesized in the liver. Essential for hemostasis.

4. Immune Defense

Immunoglobulins (IgG, IgA, IgM, IgD, IgE) in the γ-globulin fraction act as antibodies. Complement proteins aid in innate immunity.

5. Buffer Action

Plasma proteins act as buffers due to ionizable -COOH and -NH₂ groups. They contribute ~15% of buffering capacity of blood.

6. Acute Phase Proteins

During inflammation, liver increases synthesis of CRP (C-reactive protein), α1-antitrypsin, haptoglobin - these are acute phase reactants.

A/G Ratio (Albumin : Globulin Ratio)

Formula:

Globulin = Total protein - Albumin A/G ratio = Albumin ÷ Globulin

Normal value: 1.2 to 1.8 : 1 (albumin is always MORE than globulin normally)

Clinical Significance

In disease, albumin falls and globulins rise simultaneously → A/G ratio decreases or gets "reversed" (becomes <1).

Condition	Change in A/G ratio
Liver cirrhosis / hepatitis	Decreased
Nephrotic syndrome	Decreased (albumin lost in urine)
Protein malnutrition (Kwashiorkor)	Decreased
Multiple myeloma	Reversed (massive globulin rise)
Kala-azar	Reversed
Autoimmune hepatitis	Reversed

Why is it useful?

Because both albumin and globulin move in opposite directions in disease, the ratio amplifies the abnormality - making it a sensitive indicator of diseases like liver failure, nephrotic syndrome, and myeloma.

Remember: Normal = A > G. Reversed = G > A (pathological).

Key one-liners to remember:

Total protein = 6-8 g/dL; Albumin = 3.5-5 g/dL
Albumin = main osmotic protein + main transport protein
A/G ratio normal = 1.2-1.8; reversed in liver disease, nephrotic syndrome, myeloma
Fibrinogen is removed in serum (so serum has no fibrinogen; plasma does)

Immunoglobulins structure types and functions 5 marks mbbs

Finding Sources

Reading File

Loading Image

I now have everything needed. Here is a complete, exam-ready MBBS 1st year answer:

Immunoglobulins - Structure, Types and Functions

(5 Marks - MBBS 1st Year)

Definition

Immunoglobulins (Ig) are glycoproteins produced by plasma cells (differentiated B lymphocytes) that function as antibodies. They are found in the γ-globulin fraction of plasma proteins.

Basic Structure of Immunoglobulin (IgG as prototype)

All immunoglobulins are built on a basic four-chain unit (monomer):

Chains

2 Heavy (H) chains - larger (~50-70 kDa each)
2 Light (L) chains - smaller (~23 kDa each)
Held together by inter-chain disulfide bonds (-S-S-) and non-covalent forces

Regions on each chain

Each chain has:

Variable (V) region - N-terminal end; differs between antibodies; forms the antigen-binding site
Constant (C) region - C-terminal end; same within a class; determines effector functions

Light Chains

Two types: Kappa (κ) and Lambda (λ)

A single Ig molecule always has either 2κ or 2λ, never mixed
In humans, κ chains predominate

Heavy Chains

Each class has a distinct heavy chain:

Class	Heavy chain
IgG	γ (gamma)
IgA	α (alpha)
IgM	μ (mu)
IgD	δ (delta)
IgE	ε (epsilon)

Functional Fragments (Proteolytic Cleavage)

Immunoglobulin structure and proteolytic fragments showing Fab, Fc, and F(ab')2 regions

Enzyme	Fragments Produced
Papain	2 × Fab (Fragment Antigen Binding - each monovalent) + 1 × Fc (Fragment Crystallizable)
Pepsin	1 × F(ab')₂ (bivalent, still precipitates antigen) + pFc' (degraded)

Fab - contains VH + VL + CH1 + CL; binds antigen
Fc - contains CH2 + CH3; mediates effector functions (complement, opsonization, placental transfer)
Hinge region - between CH1 and CH2; flexible; susceptible to proteases

Types of Immunoglobulins and Their Properties

Property	IgG	IgA	IgM	IgD	IgE
% of total Ig	75%	15%	9%	0.2%	0.004%
Serum conc.	~1000 mg/dL	~200 mg/dL	~120 mg/dL	~3 mg/dL	~0.05 mg/dL
Structure	Monomer	Monomer/Dimer	Pentamer	Monomer	Monomer
Mol. weight	150 kDa	170/400 kDa	900 kDa	180 kDa	190 kDa
Sedimentation	7S	7S or 11S	19S	7S	8S

Functions of Each Class

IgG (most abundant)

Main antibody of secondary immune response
Crosses the placenta - provides passive immunity to the newborn
Opsonization - coats bacteria to enhance phagocytosis
Complement activation (classical pathway) - IgG1 and IgG3 most effective
Neutralization of toxins and viruses
Has 4 subclasses: IgG1, IgG2, IgG3, IgG4

IgA

Found in secretions (saliva, tears, breast milk, gut, respiratory mucosa) as secretory IgA (sIgA)
Dimer in secretions, joined by J chain + secretory component (SC)
First line of mucosal defense against pathogens
Protects mucosal surfaces (GIT, respiratory tract)

IgM

First antibody produced in primary immune response (earliest response)
Pentameric structure - 10 antigen binding sites (highest avidity)
Most efficient at complement activation
Antigen receptor on naive B cells (as surface monomer)
Responsible for ABO blood group agglutination (isohemagglutinins)
Contains J chain linking the 5 monomers

IgD

Found mainly on the surface of B lymphocytes as antigen receptor (along with IgM)
Very low serum levels
Role in lymphocyte activation and regulation
May protect against upper respiratory tract microbes

IgE

Present in extremely low concentrations in serum
Most IgE is bound to mast cells and basophils via high-affinity Fc receptors (FcεRI)
When antigen (allergen) cross-links IgE on mast cells → degranulation → histamine release
Mediates Type I hypersensitivity (allergic reactions) - anaphylaxis, asthma, urticaria
Plays a role in defense against helminth (worm) infections

Key Points to Remember

Feature	Remember
Most abundant	IgG (75%)
First in infection	IgM
Crosses placenta	IgG only
Found in secretions	IgA
Allergy/anaphylaxis	IgE
B cell receptor	IgM and IgD
Pentamer	IgM
Highest avidity	IgM (10 binding sites)

Sources: Roitt's Essential Immunology; Harper's Illustrated Biochemistry (32e); Medical Microbiology 9e

Mention functions and types

Asking for Preferences

Here is a focused, exam-ready summary of just the types and functions of immunoglobulins - clean and easy to write in an answer:

Immunoglobulins - Types and Functions

(MBBS 1st Year)

Types of Immunoglobulins (5 Classes)

There are 5 classes of immunoglobulins based on the heavy chain type:

Class	Heavy Chain	Structure	% in Serum
IgG	γ (gamma)	Monomer	75%
IgA	α (alpha)	Monomer / Dimer	15%
IgM	μ (mu)	Pentamer	9%
IgD	δ (delta)	Monomer	0.2%
IgE	ε (epsilon)	Monomer	0.004%

Light chains are of 2 types: Kappa (κ) and Lambda (λ) - same in all classes.

Functions of Each Type

IgG

Main antibody of secondary (anamnestic) immune response
Only Ig that crosses the placenta - provides passive immunity to newborn
Opsonization - coats bacteria, enhances phagocytosis
Complement activation (classical pathway)
Neutralizes toxins and viruses
Has 4 subclasses: IgG1, IgG2, IgG3, IgG4

IgA

Mucosal/secretory immunity - main Ig in saliva, tears, breast milk, colostrum, respiratory and GI secretions
In secretions, exists as dimer joined by J chain + secretory component (SC)
First line of defense at mucosal surfaces
Protects gut and respiratory tract from pathogen entry

IgM

First antibody produced in primary immune response (earliest to appear)
Pentameric - has 10 antigen binding sites (highest avidity of all Ig)
Most potent activator of complement (classical pathway)
Acts as antigen receptor on naive B cells (as surface monomer)
Responsible for ABO blood group agglutination (natural isohemagglutinins)

IgD

Found mainly on surface of mature B lymphocytes as antigen receptor (co-expressed with IgM)
Involved in B cell activation and regulation
Very low serum levels - exact serum function not fully clear
May have a role in defense against upper respiratory infections

IgE

Mediates Type I (immediate) hypersensitivity reactions - allergy, asthma, anaphylaxis, urticaria
Binds to mast cells and basophils via high-affinity Fc receptors (FcεRI)
When allergen cross-links IgE → mast cell degranulation → histamine, leukotrienes released
Plays a protective role in helminth (parasitic worm) infections
Lowest serum concentration but most potent in allergic reactions

Quick Memory Table

Ig	Key Function - One Line
IgG	Most abundant; crosses placenta; opsonization
IgA	Secretory; mucosal protection
IgM	First responder; strongest complement activator; pentamer
IgD	B cell surface receptor; lymphocyte regulation
IgE	Allergy and anaphylaxis; anti-helminth

Mnemonic for order of serum concentration (high to low):

G A M D E → "Go And Meet Doctor Edelman"

Structure of insulin and its maturation

Finding Sources

Reading File

Loading Image

Finding Sources

Reading File

I have all the content needed. Here is the complete exam answer:

Structure of Insulin and Its Maturation

(MBBS 1st Year - Biochemistry)

Structure of Insulin

Insulin is a small polypeptide hormone with the following structural features:

Chains

Feature	Detail
A chain	21 amino acids
B chain	30 amino acids
Total	51 amino acids, mol. wt ~5808 Da
Gene location	Short arm of chromosome 11

Disulfide Bonds (3 total)

2 interchain disulfide bonds - link A chain to B chain (at A7-B7 and A20-B19)
1 intrachain disulfide bond - within the A chain itself (at A6-A11)

These disulfide bonds are essential for the correct 3D shape and biological activity of insulin.

Proinsulin structure showing A-chain, B-chain and C-peptide with disulfide bonds and cleavage sites

Maturation (Biosynthesis) of Insulin

Insulin is synthesized in the β-cells of the Islets of Langerhans in the pancreas. It goes through 3 precursor stages before becoming active:

Step-by-Step Maturation

Gene (Chromosome 11)
        ↓  Transcription + Translation on ribosomes of RER
  PREPROINSULIN (110 amino acids)
        ↓  Signal peptide cleaved in RER lumen
    PROINSULIN (86 amino acids)
        ↓  Disulfide bonds form → correct folding
        ↓  Transferred to Golgi → packaged into secretory granules
        ↓  Proteases cleave C-peptide (+ 2 dipeptides)
  ACTIVE INSULIN (51 amino acids) + C-PEPTIDE
        ↓  Exocytosis (triggered by ↑ blood glucose)
     BLOODSTREAM

1. Preproinsulin

First product of translation on RER ribosomes
Contains: Signal peptide (24 aa) + B chain + C peptide + A chain
The hydrophobic signal peptide directs the polypeptide into the lumen of the RER and is immediately cleaved off

2. Proinsulin

Formed after signal peptide removal (86 amino acids)
Folds into correct conformation in the RER
3 disulfide bonds form between cysteine residues
Transferred to Golgi apparatus → packaged into secretory granules
Biologically inactive

3. Active Insulin + C-Peptide

Inside secretory granules, two proteases (Prohormone convertase 1 and 2) cleave the C-peptide (connecting peptide, 31 amino acids) + 2 small dipeptides
Result: Active insulin (A + B chains held by disulfide bonds) + C-peptide
Released in equimolar amounts by exocytosis
Zinc ions co-precipitate with insulin in granules → form hexameric zinc-insulin crystals for storage

Clinical Significance of C-Peptide

Point	Detail
Released equimolar with insulin	Yes - 1:1 ratio
Present in exogenous (injected) insulin?	No - commercial insulin has no C-peptide
Use	Measures endogenous β-cell function in diabetics receiving insulin injections
Half-life	Longer than insulin (~30 min vs ~5 min)

C-peptide measurement is used to distinguish Type 1 DM (low/absent C-peptide) from Type 2 DM (normal/high C-peptide) and to detect insulinoma.

Summary Table

Precursor	Location	What happens
Preproinsulin	RER (ribosomes)	Signal peptide cleaved
Proinsulin	RER → Golgi	Disulfide bonds form; folding
Active Insulin	Secretory granules	C-peptide removed by proteases
Secretion	Plasma membrane	Exocytosis triggered by ↑ glucose

Key facts to remember:

A chain = 21 aa; B chain = 30 aa; Total = 51 aa
3 disulfide bonds (2 interchain, 1 intrachain)
Order: Preproinsulin → Proinsulin → Insulin
C-peptide is released equimolar with insulin
Gene on chromosome 11
Half-life of insulin in circulation = ~5 minutes

Sources: Costanzo Physiology (7e); Ganong's Review of Medical Physiology (26e); Basic Medical Biochemistry - A Clinical Approach (6e)

Describe the biosynthesis of heme and regulation of heme synthesis 15 marks

Finding Sources

Reading File

Loading Image

I now have comprehensive content from multiple authoritative sources. Here is the full 15-mark answer:

Biosynthesis of Heme and Its Regulation

(15 Marks - MBBS 1st Year Biochemistry)

Introduction

Heme is an iron-containing porphyrin compound that serves as the prosthetic group of hemoglobin, myoglobin, cytochromes, catalase, and peroxidase. Its biosynthesis involves 8 enzymatic steps and occurs in both mitochondria and cytosol.

Major sites of heme synthesis:

Bone marrow (erythroid cells) - ~85% of total heme synthesis (for hemoglobin)
Liver - ~15% (for cytochrome P450 enzymes)

Raw materials:

Succinyl-CoA (from TCA cycle)
Glycine (non-essential amino acid)
Iron (Fe²⁺)
Pyridoxal phosphate (Vitamin B₆) - coenzyme

Steps of Heme Biosynthesis

MITOCHONDRIA - Step 1

Step 1: Formation of δ-Aminolevulinic Acid (ALA)

Succinyl-CoA + Glycine → δ-ALA + CO₂ + CoA

Enzyme: ALA synthase (ALAS) - two isoforms:
- ALAS1 - ubiquitous (all tissues, especially liver)
- ALAS2 - erythroid specific
Coenzyme: Pyridoxal phosphate (PLP/Vitamin B₆)
Location: Mitochondria
This is the committed, rate-limiting step of heme synthesis
Two molecules of ALA are produced per cycle

CYTOSOL - Steps 2 to 5

Step 2: Formation of Porphobilinogen (PBG)

2 ALA → Porphobilinogen (PBG) + 2 H₂O

Enzyme: ALA dehydratase (ALAD) / PBG synthase
Cofactor: Zinc (Zn²⁺) at active site
Inhibited by lead (Pb²⁺) - basis of lead poisoning anemia
Location: Cytosol

Step 3: Formation of Hydroxymethylbilane (HMB)

4 PBG → Hydroxymethylbilane + 4 NH₃

Enzyme: Hydroxymethylbilane synthase (HMBS) / PBG deaminase
4 PBG units condense to form a linear tetrapyrrole
Deficiency → Acute Intermittent Porphyria (AIP)
Location: Cytosol

Step 4: Formation of Uroporphyrinogen III

Hydroxymethylbilane → Uroporphyrinogen III

Enzyme: Uroporphyrinogen III synthase (UROS)
Ring closure and isomerization occurs
Deficiency → Congenital Erythropoietic Porphyria (CEP)
Location: Cytosol

Step 5: Formation of Coproporphyrinogen III

Uroporphyrinogen III → Coproporphyrinogen III + 4 CO₂

Enzyme: Uroporphyrinogen III decarboxylase (UROD)
Four acetate side chains are decarboxylated to methyl groups
Deficiency → Porphyria Cutanea Tarda (PCT) - most common porphyria
Location: Cytosol

Back to MITOCHONDRIA - Steps 6 to 8

Step 6: Formation of Protoporphyrinogen IX

Coproporphyrinogen III → Protoporphyrinogen IX + 2 CO₂

Enzyme: Coproporphyrinogen III oxidase (CPOX)
Two propionate side chains are decarboxylated and oxidized to vinyl groups
Deficiency → Hereditary Coproporphyria (HCP)
Location: Mitochondria

Step 7: Formation of Protoporphyrin IX

Protoporphyrinogen IX → Protoporphyrin IX

Enzyme: Protoporphyrinogen oxidase (PPOX)
Oxidation (removes 6 hydrogen atoms)
Deficiency → Variegate Porphyria (VP)
Location: Inner mitochondrial membrane

Step 8: Formation of HEME (Final Step)

Protoporphyrin IX + Fe²⁺ → HEME + 2H⁺

Enzyme: Ferrochelatase (FECH) / Heme synthase
Ferrous iron (Fe²⁺) is inserted into protoporphyrin IX
Also inhibited by lead (Pb²⁺)
Deficiency → Erythropoietic Protoporphyria (EPP)
Location: Inner mitochondrial membrane

Summary Pathway Diagram

Heme biosynthesis pathway from porphobilinogen to heme showing all intermediates, enzymes, and associated porphyrias

Summary Table of All 8 Steps

Step	Substrate	Product	Enzyme	Location	Deficiency/Porphyria
1	Succinyl-CoA + Glycine	δ-ALA	ALA synthase (ALAS)	Mitochondria	- (rate-limiting step)
2	2 × ALA	PBG	ALA dehydratase	Cytosol	Lead poisoning
3	4 × PBG	Hydroxymethylbilane	HMB synthase	Cytosol	AIP
4	Hydroxymethylbilane	Uroporphyrinogen III	UPG III synthase	Cytosol	CEP
5	Uroporphyrinogen III	Coproporphyrinogen III	UPG decarboxylase	Cytosol	PCT
6	Coproporphyrinogen III	Protoporphyrinogen IX	CPG oxidase	Mitochondria	HCP
7	Protoporphyrinogen IX	Protoporphyrin IX	PPG oxidase	Mitochondria	VP
8	Protoporphyrin IX + Fe²⁺	HEME	Ferrochelatase	Mitochondria	EPP

Memory aid for location: Steps 1, 6, 7, 8 in Mitochondria; Steps 2, 3, 4, 5 in Cytosol "Mito-Cyto-Cyto-Cyto-Cyto-Mito-Mito-Mito" → 1 M, 4 C, 3 M

Regulation of Heme Synthesis

Heme synthesis is regulated primarily at the level of ALAS (Step 1) - the rate-limiting enzyme.

1. Negative Feedback by Heme (Hemin)

When heme accumulates in excess, it is oxidized to hemin (Fe³⁺). Hemin inhibits ALAS1 by four mechanisms:

Mechanism	Effect
Represses transcription of ALAS1 gene	Less enzyme made
Destabilizes ALAS1 mRNA	Less translation
Blocks import of pre-ALAS1 into mitochondria	Less enzyme at site of action
Increases proteolytic degradation of ALAS1	More enzyme destroyed

Net result: ↑ Heme → ↓ ALAS1 → ↓ ALA synthesis → ↓ Heme production

2. Induction by Drugs (in Liver)

Many drugs (e.g., phenobarbital, barbiturates, griseofulvin) and environmental chemicals induce hepatic cytochrome P450 (CYP) enzymes. Since CYP proteins require heme as their prosthetic group:

Drugs → ↑ CYP synthesis → ↑ Heme consumption → ↓ Free heme → ↑ ALAS1 → ↑ ALA → ↑ Heme synthesis

This induction is also mediated by nuclear receptors (PXR, CAR) directly activating ALAS1 gene transcription. This mechanism explains the precipitation of acute porphyria attacks by drugs.

3. Nutritional Regulation (PGC-1α)

ALAS1 activity is regulated by the transcriptional co-activator PGC-1α
This links the rate of hepatic heme synthesis to nutritional and energy status
Fasting increases PGC-1α → increases ALAS1

4. Erythroid Regulation (ALAS2 - Iron Dependent)

In erythroid cells, the ALAS2 isoform is regulated differently:

Iron regulatory proteins (IRP) bind to an iron-responsive element (IRE) in the 5' UTR of ALAS2 mRNA
When iron is deficient → IRP binds IRE → blocks translation of ALAS2 → ↓ ALA synthesis
When iron is abundant → IRP does not bind → ALAS2 is freely translated → ↑ Heme synthesis

This ensures heme is only made in erythroid cells when sufficient iron is available for insertion into protoporphyrin IX.

5. Regulation by Heme of Globin Synthesis

Heme also stimulates globin synthesis by maintaining the ribosomal initiation complex in an active state. This coordinates heme and globin production so that equal amounts are made for hemoglobin assembly.

Clinically Important Inhibitors of Heme Synthesis

Inhibitor	Enzymes Inhibited	Effect
Lead (Pb²⁺)	ALA dehydratase + Ferrochelatase	Anemia + ↑ ALA + ↑ zinc protoporphyrin in RBCs
Vitamin B₆ deficiency	ALA synthase (needs PLP)	↓ ALA synthesis → microcytic, hypochromic anemia with iron overload
Iron deficiency	Ferrochelatase (no Fe²⁺ substrate)	↓ Heme → anemia

Key Points to Remember

8 enzymes involved; first step is rate-limiting
Starts and ends in mitochondria (steps 1 and 6, 7, 8)
Steps 2-5 in cytosol
Precursors: Succinyl-CoA + Glycine; coenzyme: Pyridoxal phosphate
ALA synthase (ALAS1) is the key regulatory enzyme
Heme = negative feedback regulator of ALAS1
Lead inhibits step 2 (ALAD) and step 8 (ferrochelatase)
Each enzyme deficiency causes a specific porphyria
AIP (step 3 deficiency) is the most common acute porphyria - precipitated by drugs, fasting, hormones

Sources: Lippincott's Illustrated Reviews: Biochemistry (8e); Tietz Textbook of Laboratory Medicine (7e); Basic Medical Biochemistry - A Clinical Approach (6e); Ganong's Review of Medical Physiology (26e)

Explain lead poisoning effects on heme synthesis (5 marks(3+5) marks

What are porphyria’s classify and write in detail about acute intermittent porphyria (3+5) marks

Finding Sources

Reading File

Excellent content gathered. Here are both answers:

QUESTION 1: Lead Poisoning - Effects on Heme Synthesis

(5 Marks - MBBS 1st Year)

Lead Poisoning - Overview (3 marks)

Lead (Pb) is a heavy metal toxin that affects heme synthesis by inhibiting two key enzymes in the pathway:

Mechanism of Inhibition

Lead inhibits enzymes by complexing with essential thiol (-SH) groups and displacing zinc ions (Zn²⁺) at enzyme active sites.

Enzymes Inhibited

1. ALA Dehydratase (Step 2 - Cytosol)

Normally uses Zn²⁺ as cofactor
Lead displaces Zn²⁺ → enzyme inactivated
Result: δ-ALA accumulates (cannot form PBG)

2. Ferrochelatase (Step 8 - Mitochondria)

Catalyzes insertion of Fe²⁺ into protoporphyrin IX → Heme
Lead inhibits by complexing with -SH groups
Result: Protoporphyrin IX accumulates; Fe²⁺ is replaced by Zn²⁺ to form zinc protoporphyrin (ZPP) instead of heme

Biochemical Consequences (5 marks)

Accumulated Substance	Site of Block	Test Significance
↑ δ-ALA in urine	Step 2 blocked	Diagnostic marker
↑ Porphobilinogen (mild)	Step 2 blocked	Detected in urine
↑ Protoporphyrin IX in RBCs	Step 8 blocked	Key test
↑ Zinc protoporphyrin (ZPP)	Zn²⁺ substitutes for Fe²⁺	Sensitive screening test
↑ Coproporphyrin III in urine	Back-accumulation	Detected in urine
↓ Heme	Both steps blocked	Core defect

Clinical Effects of Lead Poisoning

1. Anemia (Microcytic, Hypochromic)

↓ Heme → ↓ Hemoglobin → anemia
RBCs are small and pale

2. Neurological Toxicity

Elevated δ-ALA is neurotoxic (structurally similar to GABA)
Developmental delay, learning disabilities, low IQ (especially in children)
Encephalopathy (in severe poisoning)

3. Abdominal Symptoms

Abdominal pain, constipation, colic

4. Inhibition of Electron Transport Chain

↓ Heme → ↓ Cytochromes → impaired mitochondrial respiration → fatigue

5. Basophilic Stippling of RBCs

Lead inhibits 5'-nucleotidase → ribosomal RNA accumulates in RBCs → seen as blue stippling on blood smear (characteristic finding)

Diagnostic Tests

↑ Blood lead levels (>10 µg/dL in children)
↑ Urinary δ-ALA and coproporphyrin III
↑ Zinc protoporphyrin (ZPP) in RBCs - most sensitive screening test
Blood smear: basophilic stippling
X-ray: dense "lead lines" at metaphysis of long bones in children

Treatment

Remove source of exposure
Chelation therapy: Succimer (DMSA) or CaNa₂-EDTA for blood lead >45 µg/dL

QUESTION 2: Porphyrias - Classification and Acute Intermittent Porphyria

(3+5 Marks - MBBS 1st Year)

What are Porphyrias? (Definition)

Porphyrias are a group of inherited (or acquired) metabolic disorders resulting from deficiency of specific enzymes in the heme biosynthesis pathway. Enzyme deficiency leads to accumulation of porphyrin precursors and intermediates, which are toxic to tissues.

Classification of Porphyrias (3 Marks)

Porphyrias are classified in two ways:

A. By Site of Primary Enzyme Defect

Type	Primary Organ Affected	Examples
Hepatic Porphyrias	Liver	AIP, PCT, VP, HCP, ALADP
Erythropoietic Porphyrias	Bone marrow	CEP, EPP

B. By Clinical Features

Type	Predominant Symptoms	Examples
Acute Porphyrias	Neuropsychiatric + abdominal	AIP, VP, HCP, ALADP
Cutaneous Porphyrias	Photosensitivity/skin blisters	PCT, CEP, EPP
Mixed (both)	Both neuro + skin	VP, HCP

Summary of All Porphyrias

#	Enzyme Deficient	Porphyria	Class	Features
1	ALAS2	X-linked sideroblastic anemia	Erythropoietic	Anemia
2	ALA dehydratase	ALADP	Hepatic/Acute	Abdominal pain, neuro
3	HMB synthase (PBG deaminase)	AIP	Hepatic/Acute	Abdominal, neuro
4	UPG III synthase	CEP (Congenital EP)	Erythropoietic	Severe photosensitivity
5	UPG decarboxylase	PCT	Hepatic/Cutaneous	Skin blisters, most common
6	CPG oxidase	HCP	Hepatic/Mixed	Abdominal + skin
7	PPG oxidase	VP (Variegate Porphyria)	Hepatic/Mixed	Abdominal + skin
8	Ferrochelatase	EPP	Erythropoietic	Photosensitivity

Most common porphyria overall: PCT (Porphyria Cutanea Tarda) Most common acute porphyria: AIP (Acute Intermittent Porphyria)

Acute Intermittent Porphyria (AIP) in Detail (5 Marks)

Definition

AIP is an autosomal dominant hepatic porphyria caused by ~50% deficiency of Hydroxymethylbilane (HMB) synthase (also called PBG deaminase / Uroporphyrinogen I synthase) - the enzyme that converts PBG to hydroxymethylbilane (Step 3 of heme synthesis).

Genetics

Inheritance: Autosomal dominant (heterozygous)
Gene: HMBS gene on chromosome 11q23.3
Penetrance: Low - only ~10-20% of carriers develop symptoms
Gender: Strong female predominance (attacks often triggered by hormonal changes)
550 mutations identified in HMBS gene

Biochemical Defect

PBG → [HMB synthase - DEFICIENT] → Hydroxymethylbilane

Result: PBG and δ-ALA accumulate ↑↑↑

Accumulated PBG and δ-ALA are neurotoxic → cause all clinical features

Precipitating (Triggering) Factors

Attacks are typically triggered by factors that increase demand for heme (especially in the liver for cytochrome P450):

Category	Examples
Drugs (most common)	Barbiturates, phenytoin, sulfonamides, griseofulvin, rifampicin, OCP
Hormones	Progesterone (attacks in luteal phase of menstrual cycle)
Fasting / Low carbohydrate diet	↑ PGC-1α → ↑ ALAS1
Alcohol	Induces CYP → depletes heme
Stress / Infection	↑ Heme demand
Surgery	Stress response

Clinical Features (The Classic Triad)

1. Abdominal Pain (Most common, most prominent)

Severe, colicky, diffuse
With nausea, vomiting, constipation
May mimic "surgical abdomen" - patients often misdiagnosed and operated on

2. Neuropsychiatric Symptoms

Anxiety, confusion, hallucinations, psychosis
Peripheral neuropathy (motor > sensory) - can lead to ascending paralysis
Seizures (avoid phenytoin/barbiturates - they worsen the attack!)
Autonomic instability: tachycardia, hypertension

3. Dark (Port-wine) Urine

PBG is colorless when first voided
On standing, PBG oxidizes to porphobilin → urine turns red/dark brown/black
Classic diagnostic sign

No photosensitivity - this distinguishes AIP from cutaneous porphyrias

Laboratory Findings

Test	Finding
Urine PBG (during attack)	↑↑ Markedly elevated - KEY diagnostic test
Urine δ-ALA	↑↑ Elevated
Urine porphyrins	↑ Uroporphyrin and coproporphyrin
Watson-Schwartz test	Positive (pink-red color with Ehrlich's reagent)
RBC HMB-synthase activity	↓ (~50% of normal)
Heme in blood	Normal (since 50% enzyme activity is adequate at rest)

Watson-Schwartz Test

A bedside qualitative test: Add Ehrlich's aldehyde reagent to urine → pink/red color indicates elevated PBG. Positive in AIP (and VP, HCP) during acute attacks.

Treatment

Acute Attack:

Remove precipitating factors (stop offending drugs, treat infections)
High carbohydrate loading (IV glucose 300-400 g/day) - suppresses ALAS1 via insulin signaling
IV Hemin (Hematin/Heme arginate) - drug of choice for severe attacks
- Provides exogenous heme → inhibits ALAS1 by negative feedback → ↓ ALA and PBG
- Dose: 3-4 mg/kg/day × 4 days
Symptom control: narcotic analgesics (pain), phenothiazines (nausea), benzodiazepines (anxiety)
Givosiran (siRNA) - new therapy (FDA approved 2019) - silences ALAS1 mRNA → prevents attacks

Long-term Prevention:

Avoid known triggers
GnRH analogue (for menstrual cycle-related attacks)
High carbohydrate diet

Complications

Hypertension
Chronic kidney disease (up to 59% of symptomatic patients)
Hepatocellular carcinoma risk (regular liver imaging every 6 months recommended)
Residual motor neuropathy

Key One-Liners for AIP

Feature	Detail
Enzyme deficient	HMB synthase (PBG deaminase)
Inheritance	Autosomal dominant
Key metabolites ↑	PBG and δ-ALA
Key diagnostic test	Urine PBG ↑↑
Bedside test	Watson-Schwartz test
Classic symptom	Abdominal pain + dark urine
What's absent	No photosensitivity
Drug of choice	IV Hemin
Most common trigger	Drugs (barbiturates, phenytoin)

Sources: Harper's Illustrated Biochemistry (32e); Harrison's Principles of Internal Medicine (22e); Lippincott's Illustrated Reviews: Biochemistry (8e); Yamada's Textbook of Gastroenterology (7e)

Try again

Asking for Preferences

Enumerate hemoglobin derivatives

Finding Sources

Reading File

Finding Sources

Reading File

Here is a complete enumeration of hemoglobin derivatives, well-organized for MBBS exams:

Hemoglobin Derivatives

(MBBS 1st Year - Biochemistry)

Classification

Hemoglobin derivatives are grouped based on the nature of modification:

Category	Derivatives
Physiological (Normal)	Oxyhemoglobin, Deoxyhemoglobin, Carbaminohemoglobin, HbA1c
Abnormal/Toxic (Dyshemoglobins)	Methemoglobin, Carboxyhemoglobin, Sulfhemoglobin, Cyanmethemoglobin
Laboratory	Cyanmethemoglobin (Drabkin's solution)

1. Oxyhemoglobin (HbO₂)

Formed when O₂ binds to Hb in the lungs
Iron remains in Fe²⁺ state (oxygenation, not oxidation)
Bright cherry-red color
Normal physiological carrier of oxygen
Releases O₂ in tissues (facilitated by low pO₂, low pH, high CO₂, high temperature, high 2,3-BPG - Bohr effect)

2. Deoxyhemoglobin (Reduced Hb / HHb)

Hb after O₂ is released in tissues
Iron remains in Fe²⁺ state
Dark purplish-red color
Responsible for blue coloration (cyanosis) when >5 g/dL in blood
Also carries CO₂ and H⁺ (buffering)

3. Carbaminohemoglobin (HbCO₂)

CO₂ binds to free amino (-NH₂) groups of globin chains (not to heme iron)
Forms carbamino compounds: Hb-NH-COOH
Carries ~20-25% of CO₂ from tissues to lungs
Does NOT affect oxygen carrying capacity of heme iron
Favored in tissues (↑ CO₂, ↓ O₂)

4. Glycated Hemoglobin (HbA1c)

Hb with glucose non-enzymatically attached to the N-terminal valine of β-chains (Schiff base → Amadori product)
Normal value: 4-6% of total Hb
Not affected by short-term fluctuations in blood glucose
Reflects average blood glucose over past 2-3 months (lifetime of RBC ~120 days)
Key diagnostic test for diabetes monitoring:
- Diabetic control: <7%
- Poor control: >8%

5. Methemoglobin (MetHb / Hi)

Iron is oxidized from Fe²⁺ → Fe³⁺ (ferric state)
Cannot bind O₂ reversibly → functional anemia
Normal level: <1.5% of total Hb
Blood color: chocolate brown
Cyanosis appears at ~1.5 g/dL MetHb (vs. 5 g/dL deoxy-Hb)

Causes (acquired):

Nitrites, nitrates, chlorates
Sulfonamides, phenacetin, dapsone, aniline dyes
Ferrous sulfate (large doses)

Hereditary causes:

Deficiency of NADH-cytochrome b5 reductase (autosomal recessive)
Structurally abnormal Hb (Hb M) - tyrosine substituted for histidine in heme pocket

Reduction back to Hb:

Normally by NADH-cytochrome b5 reductase (primary)
Backup: ascorbic acid, reduced glutathione, NADPH-MetHb reductase

Treatment of toxic methemoglobinemia:

Methylene blue (IV) - activates NADPH-MetHb reductase pathway (rapid)
Ascorbic acid (for hereditary form)

6. Carboxyhemoglobin (HbCO)

Carbon monoxide (CO) binds to heme iron at the same site as O₂
Affinity of CO for Hb is 200-250 times greater than O₂
Cannot carry O₂ → causes cellular asphyxia
Also causes left shift of O₂ dissociation curve (remaining Hb binds O₂ more tightly)
Blood color: bright cherry-red (similar to HbO₂ - can mask cyanosis)
Source: car exhaust, coal gas, fires, smoking

Symptoms: Headache, dizziness, confusion, cherry-red lips → coma → death (at >60% saturation) Treatment: 100% O₂ (displaces CO); hyperbaric O₂ in severe cases Note: Pulse oximetry cannot distinguish HbCO from HbO₂ - reads falsely normal

7. Sulfhemoglobin (SHb)

Sulfur is incorporated into heme ring during oxidative hemolysis
Forms a green hemochrome (mixture of oxidized, partially denatured Hb)
Blood color: mauve-lavender (greenish)
Cannot carry O₂
Cannot be reduced back to Hb (irreversible) - remains until RBCs are destroyed
Can combine with CO to form carboxysulfhemoglobin
Normal level: <1%

Causes:

Sulfonamides, phenacetin, acetanilid
Clostridium perfringens bacteremia
Severe constipation (enterogenous cyanosis)
Exposure to hydrogen sulfide (H₂S)

Further oxidation leads to Heinz body formation (denatured Hb precipitates)

8. Cyanmethemoglobin (HiCN)

Formed when methemoglobin reacts with cyanide (CN⁻)
Has high affinity of MetHb for cyanide
Stable compound used in laboratory measurement of total Hb (Drabkin's method/Cyanmethemoglobin method - gold standard for Hb estimation)
Used therapeutically in cyanide poisoning: nitrites → MetHb → MetHb binds CN⁻ → cyanmethemoglobin (less toxic)

Quick Comparison Table

Derivative	Iron State	O₂ Carrying	Color	Key Feature
Oxyhemoglobin	Fe²⁺	✓ Yes	Cherry-red	Normal; O₂ in lungs
Deoxyhemoglobin	Fe²⁺	✓ (released)	Dark red	Normal; O₂ released
Carbaminohemoglobin	Fe²⁺	✓ Yes	-	CO₂ on globin, not heme
HbA1c	Fe²⁺	✓ Yes	-	Glucose on β-chain; diabetes marker
Methemoglobin	Fe³⁺	✗ No	Chocolate brown	Oxidized iron
Carboxyhemoglobin	Fe²⁺	✗ No	Cherry-red	CO poisoning; 200× affinity
Sulfhemoglobin	Altered ring	✗ No	Mauve-green	Irreversible; sulfonamides
Cyanmethemoglobin	Fe³⁺	✗ No	-	Lab standard; cyanide antidote basis

Dyshemoglobins = MetHb + HbCO + SHb + HiCN - collectively cannot carry O₂ and are not measured by pulse oximetry (co-oximetry needed)

Sources: Henry's Clinical Diagnosis and Management by Laboratory Methods; Tietz Textbook of Laboratory Medicine (7e)

Types of normal haemoglobin 3marks answer

Finding Sources

Here is a clean 3-mark answer:

Types of Normal Hemoglobin

(3 Marks - MBBS 1st Year)

Normal hemoglobin is a tetramer made of 4 globin chains + 4 heme groups. The type depends on which globin chains are present.

In Normal Adults

Type	Chain Composition	% in Adults	Notes
HbA	α₂β₂	~96-97%	Major adult hemoglobin
HbA₂	α₂δ₂	~2-3%	Minor adult hemoglobin
HbF	α₂γ₂	<1%	Trace in adults (major in fetus)

During Development (Developmental Sequence)

Stage	Hemoglobin	Chains
Embryonic	Hb Gower 1	ζ₂ε₂
	Hb Gower 2	α₂ε₂
	Hb Portland	ζ₂γ₂
Fetal	HbF	α₂γ₂
Adult	HbA	α₂β₂
	HbA₂	α₂δ₂

Key Points

All normal Hb types contain α-chains - encoded on chromosome 16
β, δ, γ, ε chains are encoded on chromosome 11
HbF has higher O₂ affinity than HbA (less 2,3-BPG binding) → ensures O₂ transfer from mother to fetus
HbA₂ is elevated (>3.5%) in β-thalassemia trait - important diagnostic marker
At birth: ~70% HbF, 30% HbA; by 6 months, adult proportions are established

Memory tip:

"All adults have A (α₂β₂), a bit of A2 (α₂δ₂), and a forgotten F (α₂γ₂)"

Source: Harrison's Principles of Internal Medicine (22e); Histology - A Text and Atlas

What are hemoglobinopathies describe briefly 6 marks

Finding Sources

Reading File

Finding Sources

I have sufficient content. Here is the complete 6-mark answer:

Hemoglobinopathies

(6 Marks - MBBS 1st Year)

Definition

Hemoglobinopathies are a group of inherited (genetic) disorders of hemoglobin caused either by:

Structural abnormality - abnormal globin chain sequence (qualitative defect)
Reduced synthesis of one or more globin chains (quantitative defect - thalassemias)

Over 900 hemoglobin variants have been described, but only a handful are clinically significant.

Classification

Type	Defect	Examples
Structural variants	Abnormal amino acid in globin chain	HbS, HbC, HbE, HbM
Thalassemias	Reduced/absent globin chain synthesis	α-thalassemia, β-thalassemia
Unstable Hb	Hb precipitates → Heinz bodies	Hb Köln, Hb Zürich
Hb with altered O₂ affinity	High or low affinity Hb	Hb Chesapeake (high), Hb Kansas (low)
Methemoglobinemia (Hb M)	Iron stays Fe³⁺	Hb M Boston, Hb M Saskatoon

1. Sickle Cell Disease (HbS) - Most Important

Mutation: Single point mutation in β-globin gene (chromosome 11)

Glutamic acid → Valine at position 6 of the β-chain
HbA (α₂β₂) → HbS (α₂βs₂)

Inheritance: Autosomal recessive

HbAS = Sickle cell trait (heterozygous) - usually asymptomatic, protective against malaria
HbSS = Sickle cell disease (homozygous) - severe clinical manifestations

Pathophysiology:

Under low O₂ tension → HbS polymerizes → RBCs become sickle-shaped
Sickled RBCs: rigid, occlude small vessels → vaso-occlusive crises
Sickled RBCs are fragile → hemolytic anemia

Clinical Features:

Chronic hemolytic anemia (Hb 6-9 g/dL)
Painful vaso-occlusive crises (bones, chest, abdomen)
Splenomegaly → progressive splenic infarction → autosplenectomy
Susceptibility to infections (especially encapsulated organisms)
Stroke, avascular necrosis, renal papillary necrosis

Lab findings:

Sickle cells on blood smear
↑ Reticulocytes
HbS on electrophoresis

2. Thalassemias - Most Common Hemoglobinopathy Worldwide

Defect: Reduced or absent synthesis of α or β globin chains → chain imbalance

α-Thalassemia

α-globin genes deleted (normally 4 α-globin genes)
Caused by gene deletions

Genotype	Condition	Features
-α/αα (1 gene deleted)	Silent carrier	No symptoms
--/αα or -α/-α (2 deleted)	α-thalassemia trait	Mild microcytic anemia
--/-α (3 deleted)	HbH disease	Moderate hemolytic anemia; HbH (β₄ tetramers)
--/-- (4 deleted)	Hb Barts (hydrops fetalis)	γ₄ tetramers; fatal in utero

β-Thalassemia

β-globin gene mutations (point mutations, deletions)
Excess α-chains precipitate → damage RBCs

Genotype	Condition	Features
β/β⁺ or β/β⁰	Thalassemia minor (trait)	Mild anemia, ↑HbA₂ (>3.5%)
β⁺/β⁺ or β⁰/β⁺	Thalassemia intermedia	Moderate anemia, splenomegaly
β⁰/β⁰	Thalassemia major (Cooley's anemia)	Severe; transfusion dependent from infancy

Thalassemia major features:

Severe microcytic, hypochromic anemia
Hepatosplenomegaly (extramedullary hematopoiesis)
"Hair on end" skull X-ray (marrow expansion)
Frontal bossing, "chipmunk face"
Growth retardation
HbF elevated (compensatory)

3. HbC

Glutamic acid → Lysine at position 6 of β-chain
Common in West African populations
HbCC: mild hemolytic anemia, target cells on smear
HbSC: moderate sickle cell disease

4. HbE

Glutamic acid → Lysine at position 26 of β-chain
Common in Southeast Asia
HbEE: mild microcytic anemia
HbE + β-thalassemia: severe, resembles thalassemia major

Summary Table

Hemoglobinopathy	Defect	Key Feature
Sickle cell disease	Glu→Val at β6	Vaso-occlusion, hemolysis
β-Thalassemia major	↓/absent β-chain	Transfusion dependent, chipmunk face
α-Thalassemia	α-gene deletions	HbH disease, hydrops fetalis
HbC	Glu→Lys at β6	Mild hemolysis, target cells
HbE	Glu→Lys at β26	Common in SE Asia, mild anemia

Key fact to remember:

All structural hemoglobinopathies = qualitative defect (wrong amino acid) All thalassemias = quantitative defect (less/no chain made) Most common hemoglobinopathy worldwide = β-thalassemia trait Most common structural hemoglobinopathy = Sickle cell disease

Sources: Tietz Textbook of Laboratory Medicine (7e); Harrison's Principles of Internal Medicine (22e); Thompson & Thompson Genetics and Genomics in Medicine (9e)

Detail on sickle cell anaemia (molecular basis classsification consequences diagnosis complications treatment partial advantage 5 marks and short note on thalassemia 5marks

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive content from authoritative sources. Here are both complete answers:

SICKLE CELL ANAEMIA

(5 Marks - MBBS 1st Year)

Definition

Sickle cell anaemia is an autosomal recessive hemoglobinopathy caused by a single point mutation in the β-globin gene, resulting in abnormal hemoglobin S (HbS) that polymerizes under deoxygenated conditions, distorting RBCs into a sickle shape.

Molecular Basis

Mutation: Single nucleotide substitution in codon 6 of the β-globin gene (chromosome 11):

GAG → GTG (Adenine → Thymidine)

Result: Glutamic acid (Glu) → Valine (Val) at position 6 of the β-chain

Normal HbA	Sickle HbS
α₂β₂ (β has Glu at position 6)	α₂βs₂ (βs has Val at position 6)

Why does this matter?

Glutamic acid is polar, charged (hydrophilic)
Valine is non-polar (hydrophobic)
Substitution creates a hydrophobic "sticky patch" on HbS
Under low O₂ tension (deoxygenation), HbS molecules polymerize into long rigid fibers
Polymer formation → sickle-shaped RBCs (drepanocytes)
On re-oxygenation, polymers disaggregate → reversible sickling initially, but repeated cycles cause irreversible membrane damage

Classification

Genotype	Type	Features
HbSS	Sickle cell disease (homozygous)	Severe; full clinical manifestations
HbAS	Sickle cell trait (heterozygous)	Usually asymptomatic; protective against malaria
HbSC	SC disease	Moderate; both HbS and HbC
HbS + β-thalassemia	Sickle-thal	Variable severity
HbSS + HbF ↑	Ameliorated SCD	HbF inhibits polymerization → milder

Consequences / Pathophysiology

Sickling causes two main problems:

1. Hemolytic Anaemia

Sickled cells are rigid and fragile → destroyed by macrophages (extravascular hemolysis) or lysed in vessels (intravascular hemolysis)
RBC lifespan reduced from 120 days to 10-20 days
Chronic hemolytic anaemia (Hb ~6-9 g/dL)
↑ Bilirubin → jaundice, pigment gallstones

2. Vaso-occlusion

Rigid sickle cells + activated endothelium → block small blood vessels
Causes tissue ischemia and infarction
Affects: bones, lungs, brain, spleen, kidneys, penis

Complications

Organ/System	Complication
Blood	Chronic hemolytic anaemia, aplastic crisis (Parvovirus B19)
Bones	Painful vaso-occlusive crisis, avascular necrosis (femoral head), dactylitis (hand-foot syndrome in children)
Spleen	Splenic sequestration → autosplenectomy by adulthood
Lungs	Acute chest syndrome (fever + chest pain + infiltrates)
Brain	Stroke (ischemic), cognitive impairment
Kidney	Renal papillary necrosis, hematuria, renal failure
Eyes	Proliferative retinopathy → blindness
Penis	Priapism
Liver	Hepatomegaly, cholelithiasis (pigment stones)
Infections	↑ susceptibility (especially encapsulated organisms - pneumococcus, Hib) due to splenic dysfunction

Diagnosis

Blood smear: Sickle cells (drepanocytes), target cells, polychromasia, nucleated RBCs

Haematological findings:

Hb: 6-9 g/dL
↑ Reticulocyte count (5-15%)
↑ Bilirubin (unconjugated)
↑ LDH

Specific tests:

Test	Findings
Hb Electrophoresis	HbS (~90%), no HbA, ↑ HbF; gold standard
HPLC	Confirms HbS (most accurate)
Sickling test (Sickledex/Solubility test)	HbS becomes insoluble in deoxygenated solution → turbid (positive)
Sickle preparation (sodium metabisulfite)	RBCs sickle under microscope
Newborn screening	Heel prick - HPLC/IEF (identifies HbFS pattern)
Prenatal diagnosis	DNA analysis of chorionic villi or amniocentesis

Treatment

Supportive

Folic acid supplementation (↑ erythropoiesis demand)
Prophylactic penicillin (from infancy, due to functional asplenia)
Vaccinations: pneumococcal, Hib, meningococcal, influenza
Pain management: NSAIDs, opioids during crises
Blood transfusions: for severe anaemia, stroke prevention, acute chest syndrome

Disease-Modifying

Hydroxyurea - drug of choice
- Increases HbF production → HbF inhibits HbS polymerization
- Reduces sickling, frequency of painful crises, acute chest syndrome, transfusion need
- Mechanism: activates guanylate cyclase → ↑ cGMP → reactivates γ-globin gene
Voxelotor - prevents HbS polymerization directly (newer agent)
Crizanlizumab - anti-P-selectin antibody, reduces vaso-occlusive crises

Curative

Allogeneic haematopoietic stem cell transplantation (HSCT) - only cure currently
- Best results in children with matched sibling donor
Gene therapy (CRISPR-Cas9) - reactivates γ-globin or corrects HBB mutation (emerging)

Partial Advantage (Heterozygote Advantage)

Sickle cell trait (HbAS) confers ~90% protection against severe Plasmodium falciparum malaria.

Mechanisms of protection:

Sickling in parasitized RBCs: Low O₂ in capillaries → RBCs with parasites sickle → phagocytosed before parasites mature
Impaired parasite growth: Sickle cells are a hostile environment - ↓ K⁺, ↓ pH, altered membrane → poor parasite survival
Enhanced immune clearance: Sickled infected cells are more readily recognized and destroyed by macrophages
Reduced rosetting: HbS reduces RBC-RBC adhesion that P. falciparum uses to evade immunity

This explains why sickle cell gene is maintained at high frequency (up to 40-50%) in malaria-endemic regions of Sub-Saharan Africa, Middle East, and South Asia - a classic example of balanced polymorphism (heterozygote advantage preserves a harmful recessive allele in the population).

SHORT NOTE ON THALASSEMIA

(5 Marks - MBBS 1st Year)

Definition

Thalassemias are a group of inherited autosomal recessive disorders caused by reduced or absent synthesis of one or more globin chains of hemoglobin, leading to chain imbalance, ineffective erythropoiesis, and hemolytic anaemia.

The name comes from Greek: "thalassa" (sea) - as they were first described around the Mediterranean Sea

Classification

A. By Globin Chain Affected

Type	Defective Chain	Chromosome	Molecular Defect
α-Thalassemia	α-globin	16	Gene deletions (mainly)
β-Thalassemia	β-globin	11	Point mutations (mainly)

β-Thalassemia

Molecular defects: >400 point mutations affecting:

Transcription (promoter mutations)
RNA splicing (most common)
Translation (nonsense codons, frameshifts)

β⁰ = no β-chain produced | β⁺ = reduced β-chain produced

Type	Genotype	Hb level	Clinical Features
β-Thalassemia minor (trait)	β/β⁰ or β/β⁺	Mild ↓ (10-13 g/dL)	Usually asymptomatic; microcytic hypochromic RBCs
β-Thalassemia intermedia	β⁺/β⁺ or β⁰/β⁺	Moderate ↓ (7-10 g/dL)	Moderate anaemia; splenomegaly; not always transfusion-dependent
β-Thalassemia major (Cooley's anaemia)	β⁰/β⁰	Severe ↓ (<7 g/dL)	Severe; transfusion-dependent from 6 months of age

Pathophysiology of β-Thalassemia major:

↓ β-chains → ↓ HbA formation → microcytic hypochromic anaemia
Excess α-chains accumulate → form toxic precipitates → damage RBC membrane
Ineffective erythropoiesis: erythroid precursors die in bone marrow by apoptosis
Compensatory: bone marrow expansion → bony deformities; extramedullary haematopoiesis → organomegaly
↑ Iron absorption (due to ↓ hepcidin) → iron overload even without transfusions

Clinical Features of β-Thalassemia major:

Severe microcytic, hypochromic anaemia (presents at 6 months - when HbF is replaced by HbA)
Hepatosplenomegaly (extramedullary haematopoiesis)
Skeletal deformities: frontal bossing, prominent cheek bones, "chipmunk face"
"Hair-on-end" skull X-ray appearance (marrow expansion)
Failure to thrive, growth retardation
Iron overload: cardiac failure, liver cirrhosis, diabetes, hypogonadism (from transfusions + ↑ absorption)
Jaundice, gallstones

α-Thalassemia

Molecular defects: Mainly gene deletions (4 α-globin genes total - 2 on each chromosome 16)

Genes Deleted	Type	Clinical Features	Abnormal Hb
1 gene (-α/αα)	Silent carrier	Normal	None
2 genes (--/αα or -α/-α)	α-Thalassemia trait	Mild microcytic anaemia	None significant
3 genes (--/-α)	HbH disease	Moderate haemolytic anaemia; splenomegaly	HbH (β₄)
4 genes (--/--)	Hydrops fetalis	Fatal in utero/at birth	Hb Barts (γ₄)

HbH (β₄ tetramers) and Hb Barts (γ₄) have very high O₂ affinity → useless for O₂ delivery
Hydrops fetalis: severe oedema, ascites, cardiac failure in fetus → stillbirth

Diagnosis

Test	β-Thalassemia minor	β-Thalassemia major
CBC	Microcytic hypochromic anaemia (mild)	Severe microcytic hypochromic anaemia
Blood smear	Target cells, basophilic stippling	Target cells, nucleated RBCs, poikilocytosis
Hb electrophoresis	↑ HbA₂ (>3.5%) - diagnostic	↑ HbF, absent/↓ HbA, ↑ HbA₂
Serum iron/ferritin	Normal or ↑ (unlike iron deficiency)	↑↑
DNA analysis	Identifies specific mutation	Confirms diagnosis

Key: ↑ HbA₂ (>3.5%) is the hallmark of β-thalassemia minor/trait

Treatment

Condition	Treatment
Thalassemia minor	Genetic counseling; folic acid; iron only if truly deficient
HbH disease	Folic acid; transfusions during crises
Thalassemia major	Regular blood transfusions every 2-5 weeks (maintain Hb >9-10.5 g/dL)
Iron overload	Iron chelation: Deferasirox (oral, preferred), Deferoxamine (SC infusion), Deferiprone
Splenectomy	If hypersplenism increases transfusion requirements
Curative	Allogeneic HSCT (bone marrow transplant) - best in young patients with matched sibling donor
Emerging	Gene therapy (CRISPR-Cas9, lentiviral vectors); Luspatercept (reduces ineffective erythropoiesis)

Thalassemia and Malaria (Advantage)

Like sickle cell, thalassemia genes are most frequent in malaria-endemic regions
Thalassemia carriers have partial protection against P. falciparum malaria - another example of balanced polymorphism

Key one-liners:

Thalassemia = quantitative defect (less/no chain); SCD = qualitative defect (wrong chain)
β-thalassemia major diagnosed at ~6 months (when HbF falls and HbA is expected)
HbA₂ >3.5% = β-thalassemia trait
"Chipmunk face" + hair-on-end X-ray = β-thalassemia major
Curative treatment = bone marrow transplant

Sources: Goldman-Cecil Medicine (2 Vol. Set); Robbins & Kumar Basic Pathology; Robbins, Cotran & Kumar Pathologic Basis of Disease

What is jaundice and types of jaundice and explain findings in urine and blood

Finding Sources

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

What is jaundice and types of jaundice and explain findings in urine and blood

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

This is a shared conversation. Sign in to Orris to start your own chat.